114 related articles for article (PubMed ID: 12022447)
1. Immunomodulation by biphalin, dimeric synthetic opioid peptide, and its analog.
Mehrotra S; Prajapati RK; Haq W; Singh VK
Immunopharmacol Immunotoxicol; 2002 Feb; 24(1):83-96. PubMed ID: 12022447
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors.
Feliciani F; Pinnen F; Stefanucci A; Costante R; Cacciatore I; Lucente G; Mollica A
Mini Rev Med Chem; 2013 Jan; 13(1):11-33. PubMed ID: 22512573
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation by opioid peptidomimetic compound.
Narayan P; Singh VK; Agarwal SS; Tandon R; Haq W; Raghubir R; Dhar MM
Neuroimmunomodulation; 2001; 9(3):134-40. PubMed ID: 11752886
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin.
Lipkowski AW; Misicka A; Davis P; Stropova D; Janders J; Lachwa M; Porreca F; Yamamura HI; Hruby VJ
Bioorg Med Chem Lett; 1999 Sep; 9(18):2763-6. PubMed ID: 10509931
[TBL] [Abstract][Full Text] [Related]
5. Potent biphalin analogs with µ/δ mixed opioid activity: in vivo and in vitro biological evaluation.
Costante R; Pinnen F; Stefanucci A; Mollica A
Arch Pharm (Weinheim); 2014 May; 347(5):305-12. PubMed ID: 24798820
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of the first cyclic biphalin analogues.
Mollica A; Davis P; Ma SW; Porreca F; Lai J; Hruby VJ
Bioorg Med Chem Lett; 2006 Jan; 16(2):367-72. PubMed ID: 16275086
[TBL] [Abstract][Full Text] [Related]
7. Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture.
Shen KF; Crain SM
Brain Res; 1995 Dec; 701(1-2):158-66. PubMed ID: 8925279
[TBL] [Abstract][Full Text] [Related]
8. Solution Phase Peptide Synthesis: The Case of Biphalin.
Tymecka D; Misicka A
Methods Mol Biol; 2020; 2103():1-11. PubMed ID: 31879915
[TBL] [Abstract][Full Text] [Related]
9. Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
Abbruscato TJ; Williams SA; Misicka A; Lipkowski AW; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1996 Mar; 276(3):1049-57. PubMed ID: 8786534
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkers.
Mollica A; Davis P; Ma SW; Lai J; Porreca F; Hruby VJ
Bioorg Med Chem Lett; 2005 May; 15(10):2471-5. PubMed ID: 15863299
[TBL] [Abstract][Full Text] [Related]
11. Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
Redkiewicz P; Dyniewicz J; Misicka A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768778
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological properties of a new fluorescent opioid peptide analog.
Lukowiak M; Kosson P; Hennink WE; Lipkowski AW
Pharmacol Rep; 2009; 61(4):727-31. PubMed ID: 19815956
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
Horan PJ; Mattia A; Bilsky EJ; Weber S; Davis TP; Yamamura HI; Malatynska E; Appleyard SM; Slaninova J; Misicka A
J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
[TBL] [Abstract][Full Text] [Related]
14. Biphalin analogs containing β(3)-homo-amino acids at the 4,4' positions: Synthesis and opioid activity profiles.
Frączak O; Lasota A; Kosson P; Leśniak A; Muchowska A; Lipkowski AW; Olma A
Peptides; 2015 Apr; 66():13-8. PubMed ID: 25708417
[TBL] [Abstract][Full Text] [Related]
15. A molecular dynamics study on opioid activities of biphalin molecule.
Hsieh JY; Chiang TY; Chen JL; Chen YW; Lin HC; Hwang CC
J Mol Model; 2011 Oct; 17(10):2455-64. PubMed ID: 21181216
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by ethanolic extract of Boerhaavia diffusa roots.
Mehrotra S; Mishra KP; Maurya R; Srimal RC; Singh VK
Int Immunopharmacol; 2002 Jun; 2(7):987-96. PubMed ID: 12188040
[TBL] [Abstract][Full Text] [Related]
17. Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry.
Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
J Neurochem; 1997 Sep; 69(3):1236-45. PubMed ID: 9282948
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides.
House RV; Thomas PT; Bhargava HN
Peptides; 1996; 17(1):75-81. PubMed ID: 8822513
[TBL] [Abstract][Full Text] [Related]
19. Interaction of a highly potent dimeric enkephalin analog, biphalin, with model membranes.
Romanowski M; Zhu X; Ramaswami V; Misicka A; Lipkowski AW; Hruby VJ; O'Brien DF
Biochim Biophys Acta; 1997 Oct; 1329(2):245-58. PubMed ID: 9371416
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
